Literature DB >> 17251528

NSAID trials and the choice of comparators--questions of public health importance.

Bruce M Psaty1, Noel S Weiss.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17251528     DOI: 10.1056/NEJMp068286

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Do we learn the right things from clinical trials?

Authors:  Silvio Garattini; Vittorio Bertele'
Journal:  Eur J Clin Pharmacol       Date:  2008-01-29       Impact factor: 2.953

2.  Comparator bias: why comparisons must address genuine uncertainties.

Authors:  Howard Mann; Benjamin Djulbegovic
Journal:  J R Soc Med       Date:  2013-01       Impact factor: 5.344

Review 3.  The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review.

Authors:  Waheed Asghar; Fakhreddin Jamali
Journal:  Inflammopharmacology       Date:  2014-12-17       Impact factor: 4.473

Review 4.  Clinical use and pharmacological properties of selective COX-2 inhibitors.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2007-11-13       Impact factor: 2.953

5.  Review of quality assessment tools for the evaluation of pharmacoepidemiological safety studies.

Authors:  George A Neyarapally; Tarek A Hammad; Simone P Pinheiro; Solomon Iyasu
Journal:  BMJ Open       Date:  2012-09-25       Impact factor: 2.692

6.  Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study.

Authors:  Anne-Marie Schjerning Olsen; Emil L Fosbøl; Jesper Lindhardsen; Charlotte Andersson; Fredrik Folke; Mia B Nielsen; Lars Køber; Peter R Hansen; Christian Torp-Pedersen; Gunnar H Gislason
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

7.  Decisions by regulatory agencies: are they evidence-based?

Authors:  Curt D Furberg
Journal:  Trials       Date:  2007-04-11       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.